BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

190 related articles for article (PubMed ID: 25444799)

  • 1. Replication of live attenuated cold-adapted H2N2 influenza virus vaccine candidates in non human primates.
    Broadbent AJ; Santos CP; Paskel M; Matsuoka Y; Lu J; Chen Z; Jin H; Subbarao K
    Vaccine; 2015 Jan; 33(1):193-200. PubMed ID: 25444799
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Evaluation of replication, immunogenicity and protective efficacy of a live attenuated cold-adapted pandemic H1N1 influenza virus vaccine in non-human primates.
    Boonnak K; Paskel M; Matsuoka Y; Vogel L; Subbarao K
    Vaccine; 2012 Aug; 30(38):5603-10. PubMed ID: 22789506
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Genetic stability of live attenuated vaccines against potentially pandemic influenza viruses.
    Kiseleva I; Dubrovina I; Fedorova E; Larionova N; Isakova-Sivak I; Bazhenova E; Pisareva M; Kuznetsova V; Flores J; Rudenko L
    Vaccine; 2015 Dec; 33(49):7008-14. PubMed ID: 26432909
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Evaluation of three live attenuated H2 pandemic influenza vaccine candidates in mice and ferrets.
    Chen GL; Lamirande EW; Cheng X; Torres-Velez F; Orandle M; Jin H; Kemble G; Subbarao K
    J Virol; 2014 Mar; 88(5):2867-76. PubMed ID: 24371061
    [TBL] [Abstract][Full Text] [Related]  

  • 5. An open-label phase I trial of a live attenuated H2N2 influenza virus vaccine in healthy adults.
    Talaat KR; Karron RA; Liang PH; McMahon BA; Luke CJ; Thumar B; Chen GL; Min JY; Lamirande EW; Jin H; Coelingh KL; Kemble GW; Subbarao K
    Influenza Other Respir Viruses; 2013 Jan; 7(1):66-73. PubMed ID: 22417012
    [TBL] [Abstract][Full Text] [Related]  

  • 6. African green monkeys recapitulate the clinical experience with replication of live attenuated pandemic influenza virus vaccine candidates.
    Matsuoka Y; Suguitan A; Orandle M; Paskel M; Boonnak K; Gardner DJ; Feldmann F; Feldmann H; Marino M; Jin H; Kemble G; Subbarao K
    J Virol; 2014 Jul; 88(14):8139-52. PubMed ID: 24807726
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Safety, immunogencity, and efficacy of a cold-adapted A/Ann Arbor/6/60 (H2N2) vaccine in mice and ferrets.
    Chen GL; Lamirande EW; Jin H; Kemble G; Subbarao K
    Virology; 2010 Mar; 398(1):109-14. PubMed ID: 20034647
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Peculiarity of reassortment of current wild type influenza viruses with master donor viruses for live influenza vaccine].
    Kiseleva IV; Bazhenova EA; Larionova NV; Fedorova EA; Dubrovina IA; Isakova-Sivak IN; Rudenko LG
    Vopr Virusol; 2013; 58(5):26-31. PubMed ID: 24640168
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Varying Viral Replication and Disease Profiles of H2N2 Influenza in Ferrets Is Associated with Virus Isolate and Inoculation Route.
    van de Ven K; van Dijken H; Du W; de Heij F; Mouthaan J; Spijkers S; van den Brink S; Roholl P; de Haan CAM; de Jonge J
    J Virol; 2022 Jul; 96(14):e0073222. PubMed ID: 35862678
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A Single Dose of an Avian H3N8 Influenza Virus Vaccine Is Highly Immunogenic and Efficacious against a Recently Emerged Seal Influenza Virus in Mice and Ferrets.
    Baz M; Paskel M; Matsuoka Y; Zengel JR; Cheng X; Treanor JJ; Jin H; Subbarao K
    J Virol; 2015 Jul; 89(13):6907-17. PubMed ID: 25903333
    [TBL] [Abstract][Full Text] [Related]  

  • 11. H2N2 live attenuated influenza vaccine is safe and immunogenic for healthy adult volunteers.
    Isakova-Sivak I; Stukova M; Erofeeva M; Naykhin A; Donina S; Petukhova G; Kuznetsova V; Kiseleva I; Smolonogina T; Dubrovina I; Pisareva M; Nikiforova A; Power M; Flores J; Rudenko L
    Hum Vaccin Immunother; 2015; 11(4):970-82. PubMed ID: 25831405
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The attenuation phenotype conferred by the M gene of the influenza A/Ann Arbor/6/60 cold-adapted virus (H2N2) on the A/Korea/82 (H3N2) reassortant virus results from a gene constellation effect.
    Subbarao EK; Perkins M; Treanor JJ; Murphy BR
    Virus Res; 1992 Sep; 25(1-2):37-50. PubMed ID: 1413993
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The receptor binding specificity of the live attenuated influenza H2 and H6 vaccine viruses contributes to vaccine immunogenicity and protection in ferrets.
    Chen Z; Zhou H; Kim L; Jin H
    J Virol; 2012 Mar; 86(5):2780-6. PubMed ID: 22190726
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The matrix gene segment destabilizes the acid and thermal stability of the hemagglutinin of pandemic live attenuated influenza virus vaccines.
    O'Donnell CD; Vogel L; Matsuoka Y; Jin H; Subbarao K
    J Virol; 2014 Nov; 88(21):12374-84. PubMed ID: 25122789
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Master donor viruses A/Leningrad/134/17/57 (H2N2) and B/USSR/60/69 and derived reassortants used in live attenuated influenza vaccine (LAIV) do not display neurovirulent properties in a mouse model.
    Voeten JT; Kiseleva IV; Glansbeek HL; Basten SM; Drieszen-van der Cruijsen SK; Rudenko LG; van den Bosch H; Heldens JG
    Arch Virol; 2010 Sep; 155(9):1391-9. PubMed ID: 20532926
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Changes in sialic acid binding associated with egg adaptation decrease live attenuated influenza virus replication in human nasal epithelial cell cultures.
    Powell H; Liu H; Pekosz A
    Vaccine; 2021 Jun; 39(24):3225-3235. PubMed ID: 33985852
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Generation and characterization of a cold-adapted influenza A H9N2 reassortant as a live pandemic influenza virus vaccine candidate.
    Chen H; Matsuoka Y; Swayne D; Chen Q; Cox NJ; Murphy BR; Subbarao K
    Vaccine; 2003 Oct; 21(27-30):4430-6. PubMed ID: 14505926
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Risk assessment of H2N2 influenza viruses from the avian reservoir.
    Jones JC; Baranovich T; Marathe BM; Danner AF; Seiler JP; Franks J; Govorkova EA; Krauss S; Webster RG
    J Virol; 2014 Jan; 88(2):1175-88. PubMed ID: 24227848
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Development of Clade-Specific and Broadly Reactive Live Attenuated Influenza Virus Vaccines against Rapidly Evolving H5 Subtype Viruses.
    Boonnak K; Matsuoka Y; Wang W; Suguitan AL; Chen Z; Paskel M; Baz M; Moore I; Jin H; Subbarao K
    J Virol; 2017 Aug; 91(15):. PubMed ID: 28490598
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Four viral genes independently contribute to attenuation of live influenza A/Ann Arbor/6/60 (H2N2) cold-adapted reassortant virus vaccines.
    Snyder MH; Betts RF; DeBorde D; Tierney EL; Clements ML; Herrington D; Sears SD; Dolin R; Maassab HF; Murphy BR
    J Virol; 1988 Feb; 62(2):488-95. PubMed ID: 3336068
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.